Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Curaleaf CEO said DEA has until end of April 2024 to

<< Previous

Bullboard Posts

Next >>

Comment by subaru1on Jan 27, 2024 2:54pm

82 Views

Post# 35848716

RE:Curaleaf CEO said DEA has until end of April 2024 to

In that context, DEA’s response offered little insight, with the agency declining to address the lawmakers’ key arguments and instead simply outlining the procedural details of the scheduling review.

It also did not divulge any details about the timeline for the completion of the review, though many observers expect it to wrap up ahead of the November election.

Published 3 weeks ago.

<< Previous

Bullboard Posts

Next >>

@ the Bell: TSX advances to start off Christmas trading week